6
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Speech-Language Pathology Guidance for Tracheostomy During the COVID-19 Pandemic: An International Multidisciplinary Perspective

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          As the COVID-19 pandemic has unfolded, there has been growing recognition of risks to frontline health care workers. When caring for patients with tracheostomy, speech-language pathologists have significant exposure to mucosal surfaces, secretions, and aerosols that may harbor the SARS-CoV-2 virus. This tutorial provides guidance on practices for safely performing patient evaluation and procedures, thereby reducing risk of infection.

          Method

          Data were collated through review of literature, guidelines, and consensus statements relating to COVID-19 and similar high-consequent infections, with a focus on mitigating risk of transmission to health care workers. Particular emphasis was placed on speech-language pathologists, nurses, and other allied health professionals. A multinational interdisciplinary team then analyzed findings, arriving at recommendations through consensus via electronic communications and video conference.

          Results

          Reports of transmission of infection to health care workers in the current COVID-19 pandemic and previous outbreaks substantiate the need for safe practices. Many procedures routinely performed by speech-language pathologists have a significant risk of infection due to aerosol generation. COVID-19 testing can inform level of protective equipment, and meticulous hygiene can stem spread of nosocomial infection. Modifications to standard clinical practice in tracheostomy are often required. Personal protective equipment, including either powered air-purifying respirator or N95 mask, gloves, goggles, and gown, are needed when performing aerosol-generating procedures in patients with known or suspected COVID-19 infection.

          Conclusions

          Speech-language pathologists are often called on to assist in the care of patients with tracheostomy and known or suspected COVID-19 infection. Appropriate care of these patients is predicated on maintaining the health and safety of the health care team. Careful adherence to best practices can significantly reduce risk of infectious transmission.

          Related collections

          Author and article information

          Journal
          American Journal of Speech-Language Pathology
          Am J Speech Lang Pathol
          American Speech Language Hearing Association
          1058-0360
          1558-9110
          June 11 2020
          : 1-15
          Affiliations
          [1 ]Department of Speech Pathology, Austin Health, Melbourne, Victoria, Australia
          [2 ]Centre for Neuroscience of Speech, University of Melbourne, Victoria, Australia
          [3 ]Tracheostomy Review and Management Service, Austin Health, Melbourne, Victoria, Australia
          [4 ]Department of Nursing Faculty, Johns Hopkins University, Baltimore, MD
          [5 ]Outcomes After Critical Illness and Surgery (OACIS) Research Group, Johns Hopkins University, Baltimore, MD
          [6 ]Department of Physical Medicine & Rehabilitation, Johns Hopkins University, Baltimore, MD
          [7 ]Department of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD
          [8 ]Department of Speech Voice and Swallowing, Manchester University NHS Foundation Trust, United Kingdom
          [9 ]Department of Physiotherapy, Austin Health, Melbourne, Victoria, Australia
          [10 ]Department of Otolaryngology–Head & Neck Surgery, Stanford University School of Medicine, CA
          [11 ]Department of Respiratory Medicine, Austin Health, Melbourne, Victoria, Australia
          [12 ]Anaesthetics & Intensive Care Medicine, Manchester University NHS Foundation Trust, United Kingdom
          [13 ]Department of Otolaryngology–Head & Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY
          [14 ]Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, Tübingen, Germany
          [15 ]Redenlab, Melbourne, Victoria, Australia
          [16 ]Department of Otolaryngology–Head & Neck Surgery, University of Michigan Medical School, Ann Arbor
          Article
          10.1044/2020_AJSLP-20-00089
          32525695
          05dc6ce7-5f54-41dc-bbcd-35cf268b3c02
          © 2020
          History

          Comments

          Comment on this article